CNBC’s Angelica Peebles and Gilead chairman and CEO Daniel O’Day join 'Squawk Box' to discuss the company's new HIV ...

The Supreme Court said Friday it will review the constitutionality of the Affordable Care Act’s no-cost coverage mandates for ...

Extreme weather events related to climate change hinder the prevention and care of people infected with HIV, according to ...

The government provides HIV medicines free of charge. Yet in one indigenous territory, cases and deaths are increasing at an ...

Drought and heavy rainfall also increased the risk of HIV and sexually transmitted infections (STIs), particularly among ...

Hopkins said that lenacapavir was expected to be reviewed by the U.S. Food and Drug Administration in 2025, with the potential to dramatically reduce HIV infection. "This will be a critical next step ...

A Mountain View barber on the run after being accused of sexual assaults is believed to have HIV, Santa Clara County ...

For years, John Fleischman carried the journal of his late mentor, who died from HIV/AIDS. He finally found the perfect home ...

In addition to having more space and privacy for patients, Ireland said the new location presents a chance for the HOPE ...

People living with HIV in California were highly satisfied with telephone visits during the height of the COVID-19 pandemic ...

Interventions, such as asset-building, differential service delivery interventions, and digital interventions can help to improve health outcomes in adolescents with HIV.

Gilead's chief executive calls lenacapavir a once in a decade medicine. The HIV treatment could push Gilead stock further up ...